Systemic inflammatory markers such as C-reactive protein (CRP), fibrinogen, ferritin, albumin, transferrin, and blood leukocyte components like neutrophils and lymphocytes are associated with prognosis of RCC, colorectal, and breast cancers [10-12]. This evidence concerns the gene ALB and renal cell carcinoma.